News

All the IT systems of the European Medicines Agency (EMA) will be temporarily unavailable from 6 am U.K. time on Saturday, April 16 to 6 am Sunday the 17th (U.K. time) due to essential maintenance, according to an EMA announcement released yesterday.

OmniComm has announced the signing of an agreement with Medistat Ltd.

SCRS announced that Medpace will participate as a Global Impact Partner dedicated to promoting communication and collabaration.

Bio-Optronics has announced the launch of their new Clinical Conductor CTMS product line. This update enables users to modify the software homepage to suit their needs and adapt with their workflows.

Orphan medicines have become a formidable R&D segment with robust growth that is expected to continue. Expansion is needed to cope with the issues of development and patient recruitment. An understanding of regulations, therefore, is critical.

Montrium announced the release and availability of a Cloud Qualification Document Pack for Microsoft’s Azure IaaS offering.

INC Research announced a collaboration with CISCRP to develop and implement educational initiatives.

William Looney speaks with DIA's Global Chief Executive to see how the organization is repositioning itself.

Solutions to overcoming the most frequent missteps when collecting valuable spirometry data in respiratory studies.

Medidata has acquired Intelemage, a medical image sharing and workflow management provider.

The agency is concerned about the lack of non-clinical models with good predictive properties in the oncology space.

Trend doesn't seem to fall in line with the perception of an increasingly complex trial protocol climate.

Study provides real metrics on the trial-scope affects of protocol changes-shedding fresh light on the importance of adopting new strategies to reduce select amendments.

For programs such as the Precision Medicine Initiative’s Cancer MoonShot to have a chance at success, following a set of key technology mandates will be critical.

Pediatric trials now feature increased modeling and analytics for safer drug dosing and response.

How to integrate evidence-based planning and real-world evidence to boost clinical trial productivity.

How to meet the rigorous safety and efficacy demands critical to evaluating newer targeted cancer therapies.

The smaller biopharmaceutical company perspective on mastering oncology immunotherapy clinical trials.

Click the title above to open the Applied Clinical Trials April/May 2016 issue in an interactive PDF format.